A systematic search of MEDLINE (Ovid) (1985 through October 2002), CANCERLIT (Ovid) (1985 through October 2002), and the Cochrane Library (2002, Issue 4) databases was carried out. "Bladder neoplasms" (Medical subject heading [MeSH]) was combined with "carcinoma, transitional cell" (MeSH) and "chemotherapy, adjuvant" (MeSH) and each of the following phrases used as text words: "bladder neoplasm," "bladder cancer," "transitional cell carcinoma," and "adjuvant chemotherapy." These terms were then combined with the search terms for the following study designs: practice guidelines, systematic reviews or meta-analyses, reviews, randomized controlled trials, and controlled clinical trials. A search of personal reprint files was also conducted. The Physician Data Query (PDQ) clinical trials database on the Internet was searched for reports of new or on-going trials. Relevant articles were selected and reviewed by three reviewers and the reference lists from these sources, as well as recently published review papers, were searched for additional trials.
Inclusion and exclusion criteria
All randomized controlled trials (RCTs) that compared adjuvant chemotherapy with observation in patients who had undergone cystectomy for the treatment of deep muscle-invasive transitional cell carcinoma (TCC) of the bladder were reviewed. To be eligible for inclusion in the systematic review, it was necessary that each trial provide comparisons of overall survival or disease-specific survival data. Quality of life was also considered an important outcome of interest. RCTs that compared different chemotherapy regimens were also considered.
Phase I or II trials were excluded due to the availability of RCTs and papers published in a language other than English, abstracts, letters, and editorials were also excluded.